Johnson & Johnson Vision Care, Inc. (a subsidiary of Johnson & Johnson Services, Inc.), Bausch & Lomb Incorporated (a subsidiary of Bausch Health Companies Inc.) and Alcon Inc. are Dominating in the Global Primary Angle-Closure Glaucoma Market in 2020

Global Primary Angle-Closure Glaucoma Market is expected to grow with the CAGR of 6.1% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below:

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-primary-angle-closure-glaucoma-market

Global primary angle-closure glaucoma market is a highly consolidated market which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.    

The major players dealing in global primary angle-closure glaucoma market are introducing strong range of surgical products providers along with advancement in the existing techniques and adopting strategic initiative such as acquisition, agreement and events into the market. This has helped the companies to maximize the sales with enhanced product portfolio. For instance, in June 2020, Johnson & Johnson Vision Care, Inc. has announced to donate to Optometry Cares – The American Optometric Association (AOA) Foundation and the American Academy of Optometry Foundation. The total amount of USD 0.30 million were donated by the company for the practitioner in their support to provide eye care to the community affected by COVID-19.

Johnson & Johnson Vision Care, Inc. (a subsidiary of Johnson & Johnson Services, Inc.) is dominating in the global primary angle-closure glaucoma market. The other players existing in the primary angle-closure glaucoma market are Aurolab, New World Medical, Inc., Sight Sciences, Inc., NIDEK CO., LTD, BVI, MicroSurgical Technology, Allergan (a subsidiary of AbbVie Inc.), Bausch & Lomb Incorporated (a subsidiary of Bausch Health Companies Inc.), Oertli Instrumente AG, Medisonic Equipments Pvt. Ltd., Omni Lens, APPASAMY ASSOCIATES, NOVAEYE MEDICAL, ZEISS International, Alcon Inc., LIGHTMED, Luneau Technology USA, Reichert, Inc. (a business unit of Ametek Inc.) and NEW VISION among others.

Primary Angle-Closure Glaucoma Market

Johnson & Johnson Vision Care, Inc. (a subsidiary of Johnson & Johnson Services, Inc.):

Johnson & Johnson Vision Care, Inc. (a subsidiary of Johnson & Johnson Services, Inc.) is headquartered in Florida, U.S. which was founded in 1959. The company is focused on providing innovative solutions for the most devastating disease in various therapeutic areas involving cardiovascular, immunology among others. The company provides various products under categories such as contact lens product, ocular surface care and surgical products out of which surgical products is the market focused category.

For instance,

  • In October 2019, Johnson & Johnson Vision Care, Inc. announced that they have launched a Worldwide #Connected By Sight Campaign in Honor of World Sight Day. The pledges was to provide 100,000 children with eye health education and treatment access via Sight for Kids, 1,000 sight-restoring surgeries to cataract patients via the Himalayan Cataract Project and will donate USD 1 to Sight for Kids or the Himalayan Cataract Project for each photo uploaded to Donate a Photo. This initiative has helped the company to give their product to be used to increase the company presence for the vision care product.

The company has wide presence across Americas, Europe, Middle East and Africa and Asia-Pacific.

Bausch & Lomb Incorporated (a subsidiary of Bausch Health Companies Inc.):

Bausch & Lomb Incorporated (a subsidiary of Bausch Health Companies Inc.) is headquartered in New Jersey, U.S. and was founded in 1853. The company is focused in empowering individuals to detect and learn about their well-being through non-invasive, cost-effective, at-home diagnostics solutions. The company has wide range of products under categories such as contact lenses, contact lens care, Rx pharmaceuticals, eye vitamins, surgical instruments, cataract surgery, orthokeratology, vitreoretinal surgery, laser system, veterinary ophthalmology and diagnostics out of which cataract surgery is the market focused category.

For instance,

  • In October 2017, Bausch & Lomb Incorporated announced that they have received 510 (k) clearance for the new 3.3 software package from the FDA with new hardware for the new Victus femtosecond laser platform which together are designed to enhance the Victus user experience. This has made the advanced changes in the system and increased the product efficacy.

The company has presence in North America, South America, Europe, Asia-Pacifica and Africa.

Alcon Inc.:

Alcon Inc. is headquartered in Geneva, Switzerland and was founded in 1945. The company is focused in innovating the cutting edge technology and transforming the way of treating the eye disease. The company deals in multiple business segments such as surgical and vision care out of which surgical is the market focused segment. The company is engaged in providing wide range of products under categories namely ocular health, contact lens and solutions, refractive technology, cataract surgery and vitreoretinal surgery in which cataract surgery is the market focused product category.

For instance,

  • In January 2021, Alcon Inc. announced that they were selected as the top employer 2021 in Europe and Brazil. Six Alcon Inc. offices were inspected and audited after that the awards were given to the company. Alcon Inc. scored highly in all survey categories particularly in the areas of Unity which is comprised of values, ethical integrity, sustainability and diversity & inclusion as well as engagement which takes into consideration for employee engagement, well-being and rewards & recognition.

The company has presence in North America, Europe, Asia-Pacific, Middle East and Africa and South America. The company has several owned subsidiaries involving Alcon Ophthalmika GmbH (Austria), N.V. Alcon S.A. (Belgium), Alcon Nordic A/S (Denmark) and AlconLab Ecuador S.A. (Ecuador) among others.